Alector, Inc. (ALEC) vs Zentalis Pharmaceuticals, Inc. (ZNTL)
A side-by-side comparison of Alector, Inc. and Zentalis Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALEC
Alector, Inc.
$1.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ZNTL
Zentalis Pharmaceuticals, Inc.
$2.67HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALEC vs ZNTL
growth of $100 · dividends reinvested · last 7yALEC -91.3% (-29.4%/yr)ZNTL -88.0% (-26.1%/yr)ZNTL compounded faster over this window
ALEC ZNTL
ALEC vs ZNTL: by the numbers
- •ALEC is the larger company ($201M vs $190M market cap).
- •Both run net losses; ZNTL's is the smaller (0.00% vs -850.13% net margin).
Metrics side by side
Valuation
| Metric | ALEC | ZNTL |
|---|---|---|
| P/S ratio | 14.50 | N/A |
| P/B ratio | N/A | 1.32 |
Profitability
| Metric | ALEC | ZNTL |
|---|---|---|
| Gross margin | 54.09% | 0.00% |
| Operating margin | -692.83% | 0.00% |
| Net margin | -850.13% | 0.00% |
| ROE | N/A | -121.76% |
| ROIC | -71.04% | -105.17% |
Growth (annualized)
| Metric | ALEC | ZNTL |
|---|---|---|
| Revenue CAGR (5Y) | -8.35% | N/A |
| Total return CAGR (5Y) | -39.17% | -47.34% |
Frequently asked
- How have ALEC and ZNTL total returns compared?
- Over the past 5 years, ALEC delivered -39.17% and ZNTL delivered -47.34% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.